Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jan 28, 2023
Discovery & Translation
CRISPR knockdown tech from Doudna lab; plus CAR Ts for myasthenia gravis and more
BioCentury’s roundup of translational news
BioCentury | Dec 7, 2022
Distillery Therapeutics
Engineered Tregs expressing an inflammation-sensing receptor for GvHD
BioCentury | Nov 14, 2020
Product Development
ASH 2020 snapshot: efficacy data in hot emerging areas
A roundup of clinical trial readouts for CD47 blockers, allogeneic CAR T cells and sickle cell disease
BioCentury | Nov 12, 2020
Product Development
Lining up allogeneic CAR Ts at ASH: Data Byte
Promising efficacy data from China’s Bioheng are among the allogeneic CAR T cell updates at ASH this year. The past year has seen a growing number of clinical readouts for off-the-shelf
BioCentury | Apr 5, 2019
Tools & Techniques
Second shot for shRNA
How tool developers and CAR T cell companies could recharge shRNA therapies
BioCentury | Jun 28, 2018
Translation in Brief
Synchronous signaling
How altering receptor motifs in CAR Ts could lead to more efficient signaling
Items per page:
1 - 10 of 20